Related Experiment Videos
Probenecid and the antibacterial activity of cephradine in vivo
Abstract:
The influence of probenecid on the concentrations in blood and antibacterial efficacy of cephradine was studied in experimentally infected mice. An infection was induced by injection of 5 X 10(6) Escherichia coli into the thighs of irradiated, granulocytopenic mice. Probenecid was given 1 hr later, just before the administration of cephradine. The control animals received only the vehicle. Concentrations of cephradine in blood were determined for 2 hr; the antibacterial activity was estimated from bacterial counts made in the homogenized individual thighs. The blood concentrations of cephradine were 1.77 times higher in the probenecid-treated animals than in the controls. The potency ratio for doses was 2.41, the potency ratio for the areas under the drug concentration in blood vs. time curves was 1.34, and that for the peak blood concentrations was 1.43.
Insights
Probenecid significantly boosted cephradine blood levels and antibacterial effectiveness in mice infected with Escherichia coli. This combination therapy shows promise for enhancing antibiotic treatment outcomes.
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Background:
- Cephradine is an antibiotic used to treat bacterial infections.
- Probenecid is a medication that can affect drug concentrations in the body.
- Understanding drug interactions is crucial for optimizing therapeutic efficacy.
Purpose of the Study:
- To investigate the impact of probenecid on cephradine's blood concentrations.
- To evaluate the influence of probenecid on the antibacterial activity of cephradine.
- To assess the combined efficacy in a murine model of infection.
Main Methods:
- Experimental infection induced with Escherichia coli in granulocytopenic mice.
- Administration of probenecid prior to cephradine dosing.
- Measurement of cephradine blood concentrations over 2 hours.
- Assessment of antibacterial activity via bacterial counts in thigh tissue.
Main Results:
- Probenecid increased cephradine blood concentrations by 1.77 times compared to controls.
- The potency ratio for doses was 2.41, indicating enhanced effectiveness.
- Area under the curve and peak concentration ratios also demonstrated increased drug exposure.
Conclusions:
- Probenecid administration enhances both the pharmacokinetic profile and antibacterial efficacy of cephradine.
- This drug interaction may offer a strategy to improve cephradine's therapeutic effectiveness in certain infections.